Detalles de la búsqueda
1.
Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study.
Diabetes Spectr
; 34(4): 407-418, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34866875
2.
Composite active range of motion (CXA) and relationship with active function in upper and lower limb spastic paresis.
Clin Rehabil
; 34(6): 803-811, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32336148
3.
Real-world effectiveness of abobotulinumtoxinA (Dysport®) in adults with upper limb spasticity in routine clinical practice: an observational study.
Neurol Neurochir Pol
; 54(1): 90-99, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31956971
4.
Assessment of Subject and Physician Satisfaction after Long-Term Treatment of Glabellar Lines with AbobotulinumtoxinA (Dysport®/Azzalure®): Primary Results of the APPEAL Noninterventional Study.
Aesthetic Plast Surg
; 42(6): 1672-1680, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30120518
5.
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.
Breast
; 74: 103681, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38377732
6.
Effects on walking of simultaneous upper/lower limb abobotulinumtoxina injections in patients with stroke or brain injury with spastic hemiparesis.
J Rehabil Med
; 51(10): 813-816, 2019 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31529136
Resultados
1 -
6
de 6
1
Próxima >
>>